About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
April 17, 2015
click here to read more
Post navigation
Previous Post
Phosphagenics Appoints Three New Directors
Next Post
Appendix 3X Notices – Three New Directors
Related Posts
Phosphagenics Market Update
September 1, 2017
Phosphagenics Featured on The RedChip Money Report Airing on Bloomberg
April 8, 2016
AGM Chairman’s Address and CEO Presentation
May 28, 2018